Keywords: arqule, 4th-qtr, loss, widens, 4m, months, ended
ArQule's 4th-qtr 2007 loss widens to $14.4M
Article | 18 February 2008
In the three months ended December 31, 2007, US biotechnology firm ArQule's loss widened to $14.4 million from $12.8 million a year ago, while ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
